Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1568 USD | +4.57% |
|
-1.94% | -27.43% |
06-18 | Transcript : Matinas BioPharma Holdings, Inc. - Special Call | |
06-13 | Matinas Biopharma Holdings, Inc.'s Oral MAT2203 Featured in Fireside Chat | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.43% | 37.62M | |
+16.28% | 121B | |
+18.86% | 112B | |
+4.43% | 22.57B | |
-18.17% | 20.82B | |
-14.06% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+2.04% | 13.17B | |
+25.76% | 11.11B |
- Stock Market
- Equities
- MTNB Stock
- News Matinas BioPharma Holdings, Inc.
- Matinas Biopharma Holdings, Inc. Announces Termination of Dominick M. Dipaolo as Its Senior Vice President of Quality and Regulatory Compliance